Blood Hemoglobin Level and Treatment Outcome of Early Breast Cancer

Strahlentherapie und Onkologie

Volumn 180, Issue 1, 2004, Pages 45-51

  Henke, Michael ^a   Sindlinger, Florian ^a   Ikenberg, Hans ^b   Gerds, Thomas ^b   Schumacher, Martin ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anemia; Breast cancer; Erythropoietin; Radiotherapy

Indexed keywords

COBALT 60; ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; RADIATION DOSE; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBINOMETRY; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 0346058022     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1123-7     Document Type: Article

References (42)

1. Antonadou D, Cardamakis E, Sarris G, et al. Effect of the administration of recombinant erythropoietin in patients with pelvic malignancies during radiotherapy. Radiother Oncol 1998;48:Suppl:483.
2. Becker A, Stadler P, Lavey RS, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radial Oncol Biol Phys 2000;46:459-66.
3. Bentzen SM, Johansen LV, Overgaard J. et al. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991;20:1197-206.
4. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957;2:359-77.
5. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radial Oncol Biol Phys 1986;12:2047-50.
6. Cartwright GE. The anemia of chronic disorders. Semin Hematol. 1966;3:351-75.
7. Cox DR. Regression models and life table (with discussion). J R Stat Soc B 1972;34:187-220.
8. Dische S. Radiotherapy and anaemia - the clinical experience. Radiother Oncol 1991;20:35-40.
9. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
10. Frommhold H, Guttenberger R, Henke M. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 1998;174:Suppl 4:31-4.
11. Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001;50:705-15.
12. Grau C, Overgaard J. Significance of hemoglobin concentration for treatment outcome, In: Molls M, Vaupel P, eds. Blood Perfusion and Microenvironment of Human Tumors. Implications for Clinical Radiooncology. Berlin-Heidelberg-New York: Springer, 2000:101-11.
13. Gray LH, Conger AD, Ebert M. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-48.
14. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
15. Henke M, Bechtold C, Momm F, et al. Blood hemoglobin level may affect radiosensitivity - preliminary results on acutely reacting normal tissues. Int J Radiat Oncol Biol Phys 2000;48:339-45.
16. Henke M, Momm F, Guttenberger R. Erythropoietin for patients undergoing radiotherapy: the Freiburg experience, In: Vaupel P, Kelleher DK, eds. Tumor Hypoxia. Pathophysiology, Clinical Significance and Therapeutic Perspectives. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999:91-7.
17. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995;332:907-11.
18. Jelkmann W, Pagel H, Wolff M, et al. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992;50:301-8.
19. Kamby C, Sengetov L. Survival and pattern of failure following locoregional recurrence of breast cancer. Clin Oncol (R Coll Radiol) 1999;11:156-63.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;54:457-81.
21. Lee WR, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998;42:1069-75.
22. Lutterbach J, Guttenberger R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. Int J Radiat Oncol Biol Phys 2000;48:1345-50.
23. Lutterbach J, Sauerbrei W, Guttenberger R. Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol 2003;179:8-15.
24. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 1993;91:416-9.
25. Mercadante S, Gebbia V, Marrazzo A, et al. Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev 2000;26:303-11.
26. Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990;322:1689-92.
27. Morganti AG, Forni F, Macchia G, et al. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure. Strahlenther Onkol 2003;179:87-92.
28. Pierquin B, Huart J, Raynal M, et al. Conservative treatment for breast cancer: long-term results (15 years). Radiother Oncol 1991;20:16-23.
29. Rauschecker HF, Sauerbrei W, Gatzemeier W, et al. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). Eur J Cancer 1998;34:315-23.
30. 2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 2001;177:462-8.
31. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989;14:177-84.
32. Schmoor C, Sauerbrei W, Bastert G, et al. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol 2000;18:1696-708.
33. Silver DF, Piver MS. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect. Gynecol Oncol 1999;73:280-4.
34. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994;69:979-85.
35. Tarnawski R, Skladowski K, Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int J Radiat Oncol Biol Phys 1997;38:1007-11.
36. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994;13:139-68.
37. Thews O, Kelleher DK, Vaupel P. Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 2001;61:1358-61.
38. Thews O, Koenig R, Kelleher DK, et al. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 1998;78:752-6.
39. Van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 1992;11:15-8.
40. Vaupel P, Thews O, Mayer A, et al. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level? Strahlenther Onkol 2002;178:727-31.
41. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990;26:668-70.
42. Henke M, Laszig R, Rübe C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trial. Lancet 2003;362:1255-60.